The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(3,5-dimethoxy-4-((3,5,6-trimethylpyrazin-2-yl)methoxy)phenyl)acrylic acid ID: ALA1909643
PubChem CID: 56930205
Max Phase: Preclinical
Molecular Formula: C19H22N2O5
Molecular Weight: 358.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=C/C(=O)O)cc(OC)c1OCc1nc(C)c(C)nc1C
Standard InChI: InChI=1S/C19H22N2O5/c1-11-12(2)21-15(13(3)20-11)10-26-19-16(24-4)8-14(6-7-18(22)23)9-17(19)25-5/h6-9H,10H2,1-5H3,(H,22,23)/b7-6+
Standard InChI Key: TWFHGFQJPVUCQZ-VOTSOKGWSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
0.0000 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7145 1.4438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4289 1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 0.6188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1434 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8579 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5724 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2868 -0.6188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5724 -1.8563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1434 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 1.8563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5724 0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8579 0.2062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.2868 1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2868 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4289 1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 -1.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7145 -1.0313 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 24 2 0
24 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 1 0
1 8 1 0
3 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
11 13 2 0
8 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
19 22 1 0
16 23 1 0
24 26 1 0
26 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.39Molecular Weight (Monoisotopic): 358.1529AlogP: 3.10#Rotatable Bonds: 7Polar Surface Area: 90.77Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.37CX Basic pKa: 1.66CX LogP: 1.25CX LogD: -1.99Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -0.10
References 1. Chen H, Li G, Zhan P, Liu X.. (2011) Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents., 46 (11): [PMID:21993151 ] [10.1016/j.ejmech.2011.09.030 ]